Sign Up to like & get recommendations! 1
Published in 2022 at "Acta Neurochirurgica"
DOI: 10.1007/s00701-022-05152-7
Abstract: Malignant ischemic infarction in the territory supplied by the middle cerebral artery is an extremely severe form of ischemic stroke associated with development of massive uncontrollable postischemic edema of the affected cerebral hemisphere; the end… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Neurosurgical Review"
DOI: 10.1007/s10143-017-0823-2
Abstract: Decompressive hemicraniectomy (DH) plus duroplasty was demonstrated to be effective for treating critically elevated intracranial pressure (ICP). In order to shorten operation time and to avoid the use of autologous or heterologous material, durotomy has… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2016.12.001
Abstract: OBJECTIVE Patients with malignant middle cerebral artery infarction frequently develop hydrocephalus after decompressive hemicraniectomy. Hydrocephalus itself and known shunt related complications after ventriculo-peritoneal shunt implantation may negatively impact patientś outcome. Here, we aimed to identify… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2016.12.069
Abstract: OBJECTIVE The aims of this study were to evaluate decompressive hemicraniectomy (DHC) versus conventional treatment (CT) for patients with malignant middle cerebral artery (MCA) infarction and to investigate the impact of age and surgical timing… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2017.02.043
Abstract: BACKGROUND Several studies have evaluated the use of decompressive hemicraniectomy (DHC) in malignant middle cerebral artery infarction (MMCAI). In the United Kingdom, the National Institute for Health and Care Excellence (NICE) has set criteria for… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "World neurosurgery"
DOI: 10.1016/j.wneu.2018.08.005
Abstract: BACKGROUND Decompressive hemicraniectomy to control medically refractory intracranial hypertension and cerebral edema and evacuate mass lesions in traumatic brain injury is a widely accepted treatment paradigm. However, the critical specifications of the bone flap size… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International Journal of Neuroscience"
DOI: 10.1080/00207454.2020.1713773
Abstract: Abstract Background The benefit of decompressive hemicraniectomy in patients with malignant acute ischemic stroke is well established, however its role in supratentorial intracerebral hemorrhages is unclear and evolving. Prior studies combined cortical and subcortical hemorrhages… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Internal Medicine Journal"
DOI: 10.1111/imj.14050
Abstract: Decompressive hemicraniectomy (DHC) has been shown to reduce mortality in malignant middle cerebral artery (MCA) infarction. Our primary objective was to compare 1‐year mortality between patients receiving DHC for malignant MCA infarction at our institution… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Stroke"
DOI: 10.1161/strokeaha.120.030804
Abstract: Background and Purpose: Young patients with malignant cerebral edema have been shown to benefit from early decompressive hemicraniectomy. The impact of concomitant infection with coronavirus disease 2019 (COVID-19) and how this should weigh in on… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "BMC Medical Imaging"
DOI: 10.1186/s12880-022-00762-0
Abstract: Background Decision-making about the indication for decompressive hemicraniectomy in cases with malignant infarction in the territory of the middle cerebral artery (MCA) is still a matter of debate. Some scores have been introduced and tested,… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Critical Care"
DOI: 10.1186/s13054-019-2452-3
Abstract: Therapeutic hypothermia (TH) is currently evaluated in acute brain injury of diverse etiologies. In the clinical trial DEPTH-SOS, Neugebauer et al. [1] reported negative results for TH (33 ± 1 °C) in malignant acute ischemic… read more here.